title: Reduction of plasma levels of prothrombin fragments 1 and 2 during thromboprophylaxis with a low-molecular-weight heparin.
abstract: In a randomized double-blind placebo-controlled study, plasma levels of prothrombin fragment 1 and 2 and total fibrin/fibrinogen degradation products were measured preoperatively and on days 1, 3, 5 and 7 postoperatively in 131 patients undergoing total hip replacement. Patients received a subcutaneous injection of either a low molecular weight heparin (Logiparin) or placebo once daily. Postoperative deep vein thrombosis was diagnosed by bilateral phlebography 7 to 10 days after operation. In the placebo group postoperative levels of prothrombin fragments 1 and 2 and total fibrin/fibrinogen degradation products were significantly higher in patients with postoperative thromboembolic complications, whereas in the low-molecular-weight heparin group no statistical differences were observed. Compared with placebo the administration of a low-molecular-weight heparin was associated with a significant reduction in the levels of prothrombin fragments 1 and 2 and total degradation products. Our observations suggest that the postoperative thrombin generation is moderated by thromboprophylaxis with Logiparin.
authors.affiliation: Dept of Orthopaedics, Aalborg Hospital, Denmark.
authors.forename: J V
authors.initials: JV
authors.lastname: Sørensen
authors.forename: M R
authors.initials: MR
authors.lastname: Lassen
authors.forename: L C
authors.initials: LC
authors.lastname: Borris
authors.forename: H B
authors.initials: HB
authors.lastname: Rahr
authors.forename: H P
authors.initials: HP
authors.lastname: Jensen
authors.forename: D
authors.initials: D
authors.lastname: Hoppensteadt
authors.forename: J A
authors.initials: JA
authors.lastname: Walenga
authors.forename: J
authors.initials: J
authors.lastname: Fareed
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004311:Double-Blind Method; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism; D006495:Heparin, Low-Molecular-Weight / Q000494:pharmacology*; D006622:Hip Prosthesis / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000378:metabolism*; D011516:Prothrombin / Q000378:metabolism*; D013924:Thrombophlebitis / Q000517:prevention & control*
chemical_list: D005338:Fibrin Fibrinogen Degradation Products; D006495:Heparin, Low-Molecular-Weight; D010446:Peptide Fragments; C045879:prothrombin fragment 1.2; D011516:Prothrombin